TET2 and peripheral T-cell lymphoma, not otherwise specified: Additionally, studies on cytotoxic peripheral T-cell lymphoma, not specifically focused on EBV+ cases, revealed frequent mutations in epigenetic modifiers, such as TET2, DNMT3A, and genes involved in the JAK/STAT pathway [19].